Gastroenterology M&A Advisory
For multi-physician GI practices, integrated platforms with ASC ownership, and groups with anesthesia, pathology, and infusion services. GI is one of the most actively consolidated specialties in healthcare M&A, with multiple well-capitalized platform buyers competing for quality practices.
Speak with an advisor: (800) 815-0590How We Help GI Sellers
Capital Partners' M&A framework is built around the specific dynamics of middle-market specialty practice transactions. The three engagement profiles below cover most of how gastroenterology practice owners come to us.
Five to twenty-five physician practices with established procedural volume, referral network, and operational infrastructure. The middle-market segment of GI M&A is exceptionally active with consistent buyer demand.
Discuss your practice →GI practices with affiliated endoscopy centers (ASCs) command meaningful valuation premiums. ASC ownership is the single largest driver of multiple expansion in GI transactions.
Discuss your platform →Practices integrated with anesthesia services, pathology labs, infusion centers, and other GI-adjacent services achieve premium valuations through revenue diversification and EBITDA mix.
Discuss your group →Market Context
Gastroenterology has been among the most consolidated specialties in middle-market healthcare M&A since 2019. Major PE-backed platforms including GI Alliance, US Digestive Health, Allied Digestive Health, One GI, Capital Digestive Care, and Pinnacle GI Partners actively acquire practices. The competitive dynamic creates meaningful pricing tension for quality groups.
The Capital Partners Approach
The maturity of the GI platform landscape means quality sellers have real choice between buyers — and the differences between platforms in terms of culture, governance, clinical autonomy, and growth trajectory can be significant. Process discipline matters here because the wrong platform fit, even at a fair headline price, can be costly over the multi-year rollover equity hold period.
GI groups considering institutional capital should think carefully about timing. Practices that come to market when their operating metrics are strong, when their physician roster is stable, and when their growth narrative is clear consistently achieve materially better outcomes than groups that come to market reactively.
Valuation Drivers
Gastroenterology practice valuation is driven by a specific set of operational, clinical, and structural factors. Below are the elements buyers evaluate most carefully when developing valuation and offer terms.
Endoscopy center ownership is the single largest valuation driver in GI M&A. ASC EBITDA, case volume, payer mix, and ownership structure all factor into buyer valuation.
Practices with integrated anesthesia services capture additional EBITDA and create meaningful valuation premium. Anesthesia ownership models vary and require careful structuring.
Owned pathology labs and integrated lab services contribute to total practice EBITDA and diversify the revenue mix. Buyers value the recurring lab revenue alongside professional fees.
Physician count, sub-specialty mix (general GI, advanced endoscopy, IBD), and post-close commitments all factor into buyer evaluation. Physician roster stability matters.
Market position in the metropolitan area, referral network density, and competitive landscape influence valuation. Multi-site operations and growth potential are evaluated.
Commercial payer mix, Medicare exposure, and demonstrated growth trajectory all contribute to buyer evaluation. Practices with consistent year-over-year growth command premium pricing.
Begin a Conversation
The most useful next step is a confidential conversation. We'll listen to your situation, give you a directional view of where your practice sits in the current market, and explain how a Capital Partners engagement would actually run. Every conversation begins under NDA.
(800) 815-0590